In addition, NTBC inhibited the proliferation of ovarian cancer cells (Figure 6E) and down‐regulated the protein levels of TPI and ENO1 in ovarian cancer cells (Figure 6F). The gene discussed is ENO1; the disease is ovarian carcinoma.